Science
CRISPR Gene Therapy Cures Sickle Cell Disease in Landmark Clinical Trial
Vertex Pharmaceuticals reported that 97% of patients treated with its CRISPR-based therapy Casgevy remained free of vaso-occlusive crises after two years, marking the most successful gene therapy outcome in history.
Vertex Pharmaceuticals reported that 97% of patients treated with its CRISPR-based therapy Casgevy remained free of vaso-occlusive crises after two years, marking the most successful gene therapy outcome in history.
Related Articles
Science
NASA's Artemis III Moon Landing Delayed Again as SpaceX Starship Faces Technical Hurdles
NASA pushed the crewed lunar landing mission to late 2027, citing delays in SpaceX's Starship Human Landing System certification. The agency is exploring backup partnerships with Blue Origin's Blue Moon lander.
Dr. Thomas Park·Jul 8, 2026
Comments(0)
No comments yet. Be the first to share your thoughts.